Register before March 2nd & Save €300
Data dictates payer decisions and has the potential to provide a new guiding light for pharma companies. We want to create a summit that catalyses the healthcare landscape into a new world. A place complete with real-world insights, aiding in the creation of true value in the eyes of the payers and regulators, and allowing patients the access to the drugs and treatments they need most.
At the Real-World Evidence and Access Europe 2018 Summit We will once again bring together the leading thought leaders and biggest industry case studies from across the continent, while also moving to ensure that speaking and participating will be all the key decision-makers in full stakeholder environment – complete with regulators, payers and HTAs.
Enhance your real-world study and analytical capabilities to provide sharper insights
Accelerate transition to a new data-led world by aligning pharma, payers and HTA around shared healthcare goals
Create a focused pipeline where every payer relationship, every dataset and every internal goal gives you total dominance of your therapy area
Ensure all departments, including clinical and R&D, are prioritising access goals and start with the patient in mind
Download the detailed event brochure here
Deputy Chief Executive
Head, Global Commercial and Market Access Strategy Organisation
Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada
VP & Head of Global Market Access
Senior Director, Head of Analytics, Real-World Informatics
Head of Real World Investigations
VP, Head of Data Generation & Business Excellence
Head of Real World Evidence, Centre of Excellence
Payer & HTA roundtable discussions
New to 2018 - key Payer and HTAs from across Europe will be joining us to lead interactive discussions. Through conversations that transcend a single pipeline and tackle more fundamental bottle necks, we can foster new ways to work together and get the bet solutions for patients faster.
The 2018 summit will bring you 2 conferences for the price of one ticket. One completely dedicated to market access, innovative pricing and reimbursement and the other dedicated to expanding the use of RWE internally across functions, building trust in RWE and influencing external decision makers.
On the day there will be two tracks (see below) across two rooms running in parallel. You will have free movement between both, allowing you to pick and choose presentations at your choice. The networking times and areas will also be shared creating a diverse mix of attendees to discuss and collaborate with.
“The event covered most of the key aspects related to RWE. I think, it was very useful. I definitely learned a lot.”
Antonio Ramirez de Arellano, Lead EU-HEOR, Novo Nordisk
“This was one of the most relevant and comprehensive conferences, which I have attended in recent years. The speakers and meeting chairs were well selected.”
Karel Mechelse, Market Access Strategy Leader, Bayer
“Well worth investing in... a place to exchange views and perspectives”
Frederic de Reydet, Global Market Access Director, Novartis
“An excellent representation of key European decision makers”
Myriam Zylberman, Senior Director - EU Payer Strategy, Eli Lilly
“A fascinating meeting of diverse speakers who outlined numerous themes around the need to prove the validity and trustworthiness of RWE, versus RCTs, with an emphasis on “real time” versus “real world”. Thank you eyeforpharma!”
Nigel Hughes, Scientific Director, Janssen
If you’re interested in getting involved in the 2018 summit, please contact us on the details below.
Global Project Director
Phone: +44 (0) 207 375 7163
Phone: +44 (0) 207 375 7203
eyeforpharma is a registered company in England and Wales - Registered number 09823909. 7-9 Fashion Street, London, E1 6PX, UK. Contact Us.
Website Development by Fruitbowl Media Ltd.